2013
DOI: 10.1016/j.annfar.2013.07.790
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-guided regional anesthesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“… 160 , 161 There is no solid evidence that ultrasound guidance significantly affects the incidence of peripheral nerve injury associated with regional anesthesia. 162 It is important to note that safety does not depend on a single technology. During the performance of regional anesthesia, safety is related to the level of training of the professional, and to the technique chosen, patient anatomy, and equipment.…”
Section: Care While Using Ultrasound-guided Regional Anesthesia Techn...mentioning
confidence: 99%
See 2 more Smart Citations
“… 160 , 161 There is no solid evidence that ultrasound guidance significantly affects the incidence of peripheral nerve injury associated with regional anesthesia. 162 It is important to note that safety does not depend on a single technology. During the performance of regional anesthesia, safety is related to the level of training of the professional, and to the technique chosen, patient anatomy, and equipment.…”
Section: Care While Using Ultrasound-guided Regional Anesthesia Techn...mentioning
confidence: 99%
“…During the performance of regional anesthesia, safety is related to the level of training of the professional, and to the technique chosen, patient anatomy, and equipment. 160 , 162 …”
Section: Care While Using Ultrasound-guided Regional Anesthesia Techn...mentioning
confidence: 99%
See 1 more Smart Citation
“…Premedication by oral dose of celecoxib 200 mg [29] and hydroxysine 25 mg will be administered in the surgical care unit. All recruited patients will receive continuous femoral nerve block (under ultrasound guidance [30]) with 2 mg/ml ropivacaine, 20 ml. In the BS+ group, patients will also receive a sciatic nerve block (subgluteal approach [31] under ultrasound guidance) with 2 mg/ml ropivacaine 20 ml.…”
Section: Trial Design and Methodsmentioning
confidence: 99%